10 Posts Not to Miss from EHA 2025
The European Hematology Association (EHA) Congress 2025 is officially underway in Milan. From June 12 to 15, hematology professionals from around the world are gathering to share the latest research, clinical advances, and innovations shaping the future of hematologic care.
EHA 2025 features a comprehensive scientific program that includes high-level plenary sessions, oral abstract presentations, clinical and translational research highlights, and disease-specific updates across malignant and non-malignant hematologic conditions. With hundreds of abstracts presented, as well as interactive education sessions and collaborative forums, the congress offers unparalleled insight into evolving standards of care, novel therapies, and mechanisms of disease.
This year’s meeting also celebrates the 30th edition of the EHA Congress, a milestone reflecting three decades of scientific excellence, global collaboration, and commitment to improving outcomes for patients with blood disorders. The program places a strong emphasis on innovation, equity, and mentorship, highlighted by prestigious award recognitions honoring leaders in the field.
Our team at OncoDaily has handpicked 10 highlights from the firts day of EHA 2025. Scroll down to catch the highlights, dive into the science, and hear directly from the people shaping the future of cancer care.
at EHA 2025 in between sessions !”
“Very productive first meeting with my mentee Thanks European Hematology Association for this mentorship program.”
To stay on top of everything happening at EHA 2025, keep following Hemostasis Today.
Written by Nare Hovhannisyan, MD
-
Nov 3, 2025, 08:23The 1st Participant in A New CHECK-NIRS Clinical Study is Enrolled!
-
Nov 3, 2025, 08:15Bert van Meurs Shares the New Late-breaking Results from the iMODERN Trial
-
Nov 3, 2025, 07:10Lisa Shea Shares Key Takeaways from NORD Summit 2025
-
Nov 3, 2025, 06:49Darshan Doshi on Results of iMODERN and ILIAS ANOCA Studies Presented at TCT 2025
-
Nov 2, 2025, 14:172019 ESC/EAS Guidelines for the Management of Dyslipidaemias Discussion with Lale Tokgözoğlu and Jeanine Roeters van Lennep
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
-
Nov 3, 2025, 04:56Nirupama Ramadas and Erica Sparkenbaugh on Thromboinflammation in SCD
-
Nov 2, 2025, 14:21Claude Franceschi: I Advise You to Understand the Hemodynamic Pathophysiology of Venous Diseases Rather than Blindly Applying Ablation Techniques or Venous Stent Placement
-
Nov 2, 2025, 14:15Krishna Aragam: Why are (DCM) and Heart Failure About Twice as Common in Individuals of Self-Identified Black Race?
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Nov 3, 2025, 09:24Stephen Cornelissen: It’s Not Just About Emergencies — It’s About Everyday Care, Chronic Conditions and Hope
-
Nov 3, 2025, 06:57Maria Elisa Mancuso Reflects on 2025 Annual Congress of the Italian Association of Hemophilia Centres
-
Nov 3, 2025, 05:46Chandra Viswanathan: When Blood Safety Fails, We All Bleed - A Call for Reform and Responsibility
-
Nov 2, 2025, 14:17Anamaria B: Your Mother Still Runs Part of Your DNA
-
Nov 2, 2025, 10:57Paul Bolaji on Launching The First Centralised Nigerian National Stroke Registry